Novel heart failure biomarkers: why do we fail to exploit their potential?

A Piek, W Du, RA de Boer… - Critical reviews in clinical …, 2018 - Taylor & Francis
Plasma biomarkers are useful tools in the diagnosis and prognosis of heart failure (HF). In
the last decade, numerous studies have aimed to identify novel HF biomarkers that would …

[PDF][PDF] Novel heart failure biomarkers: why do we fail to exploit their potential?

A Piek, W Du, RA de Boer, HHW Silljé - 2018 - core.ac.uk
Plasma biomarkers are useful tools in the diagnosis and prognosis of heart failure (HF). In
the last decade, numerous studies have aimed to identify novel HF biomarkers that would …

Novel heart failure biomarkers why do we fail to exploit their potential?

A Piek, W Du, RA de Boer, HHW Silljé - Critical reviews in clinical …, 2018 - research.rug.nl
Plasma biomarkers are useful tools in the diagnosis and prognosis of heart failure (HF). In
the last decade, numerous studies have aimed to identify novel HF biomarkers that would …

Novel heart failure biomarkers: why do we fail to exploit their potential?

A Piek, W Du, RA de Boer, HHW Silljé - Critical Reviews in Clinical …, 2018 - europepmc.org
Plasma biomarkers are useful tools in the diagnosis and prognosis of heart failure (HF). In
the last decade, numerous studies have aimed to identify novel HF biomarkers that would …

Novel heart failure biomarkers: why do we fail to exploit their potential?

A Piek, W Du, RA de Boer… - Critical reviews in …, 2018 - pubmed.ncbi.nlm.nih.gov
Plasma biomarkers are useful tools in the diagnosis and prognosis of heart failure (HF). In
the last decade, numerous studies have aimed to identify novel HF biomarkers that would …

[引用][C] Novel heart failure biomarkers: why do we fail to exploit their potential?

A Piek, W Du, RA de Boer, HHW Silljé - Critical Reviews in Clinical …, 2018 - cir.nii.ac.jp
Novel heart failure biomarkers: why do we fail to exploit their potential? | CiNii Research CiNii
国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データを …

[PDF][PDF] Novel heart failure biomarkers: why do we fail to exploit their potential?

A Piek, W Du, RA de Boer… - CRITICAL REVIEWS IN …, 2018 - researchgate.net
Plasma biomarkers are useful tools in the diagnosis and prognosis of heart failure (HF). In
the last decade, numerous studies have aimed to identify novel HF biomarkers that would …

[PDF][PDF] Novel heart failure biomarkers: Why do we fail to exploit their potential?

A Piek, W Du, RA de Boer, HHW Silljé - Novel Heart Failure …, 2019 - research.rug.nl
Plasma biomarkers are useful tools in the diagnosis and prognosis of heart failure (HF). In
the last decade, numerous studies have aimed to identify novel HF biomarkers that would …

[PDF][PDF] Novel heart failure biomarkers: Why do we fail to exploit their potential?

A Piek, W Du, RA de Boer, HHW Silljé - core.ac.uk
Plasma biomarkers are useful tools in the diagnosis and prognosis of heart failure (HF). In
the last decade, numerous studies have aimed to identify novel HF biomarkers that would …